Sabrina Ford1, Wassim Tarraf2, Karen Patricia Williams3, Lee Anne Roman4, Richard Leach5. 1. Obstetrics, Gynecology & Reproductive Biology, College of Human Medicine, Michigan State University, 965 Wilson Road, East Fee Hall, East Lansing, MI 48824, United States of America. Electronic address: sford@msu.edu. 2. Institute of Gerontology, Wayne State University, Detroit, MI 48202, United States of America. Electronic address: wassim.tarraf@wayne.edu. 3. Center for Women, Children & Youth, College of Nursing, The Ohio State University, Columbus, OH 43210, United States of America. Electronic address: williams.5963@osu.edu. 4. Obstetrics, Gynecology & Reproductive Biology, College of Human Medicine, Michigan State University, 965 Wilson Road, East Fee Hall, East Lansing, MI 48824, United States of America. Electronic address: lroman@msu.edu. 5. Obstetrics, Gynecology & Reproductive Biology, College of Human Medicine, Michigan State University, Spectrum Health Medical Group, Grand Rapids, MI 49503, United States of America. Electronic address: rleach@msu.edu.
Abstract
OBJECTIVE: To study differences in screening adherence and follow-up after an abnormal Pap test in Non-Hispanic Black (Black) and Non-Hispanic White (White) women. METHODS: An observational cohort study using 2010 National Health Interview Survey cancer module to examine HPV knowledge, screening behavior, and follow-up to abnormal Pap test in Black and White women 18 years of age or older without a hysterectomy. We fit logistic regression models to examine associations between race and primary outcome variables including: HPV awareness, Pap test in the last three years, provider recommended Pap test, received Pap test results, had an abnormal Pap test, recommended follow-up, and adhered to the recommendation for follow-up. RESULTS: Analyzing data for 7509 women, Black women had lower odds ratios [OR] for: 1) HPV awareness (71% vs 83%; OR = 0.42; 95% CI = 0.36-0.49); 2) reporting Pap screening was recommended (59% vs 64%; OR = 0.76; 95% CI = 0.66-0.88), and 3) acknowledging receipt of Pap results (92% vs 94%; OR = 0.64; 95% CI = 0.49-0.83). Group differences persisted after covariates adjustment. In adjusted models, Black women had higher odds of reporting recent Pap screening (84% vs 77%; OR = 1.7; 95% CI = 1.42-2.03), but reported lower odds of receiving a follow-up recommendation subsequent to abnormal test (78% vs 87%; OR = 0.54; 95% CI = 0.31-0.95). CONCLUSION: Black women reported higher cervical cancer screening adherence but lower rates of being informed of an abnormal Pap test and contacted for follow-up treatment. We recommend a multilevel approach to deliver culturally appropriate education and communication for patients, physicians, clinicians in training, and clinic level ancillary staff.
OBJECTIVE: To study differences in screening adherence and follow-up after an abnormal Pap test in Non-Hispanic Black (Black) and Non-Hispanic White (White) women. METHODS: An observational cohort study using 2010 National Health Interview Survey cancer module to examine HPV knowledge, screening behavior, and follow-up to abnormal Pap test in Black and White women 18 years of age or older without a hysterectomy. We fit logistic regression models to examine associations between race and primary outcome variables including: HPV awareness, Pap test in the last three years, provider recommended Pap test, received Pap test results, had an abnormal Pap test, recommended follow-up, and adhered to the recommendation for follow-up. RESULTS: Analyzing data for 7509 women, Black women had lower odds ratios [OR] for: 1) HPV awareness (71% vs 83%; OR = 0.42; 95% CI = 0.36-0.49); 2) reporting Pap screening was recommended (59% vs 64%; OR = 0.76; 95% CI = 0.66-0.88), and 3) acknowledging receipt of Pap results (92% vs 94%; OR = 0.64; 95% CI = 0.49-0.83). Group differences persisted after covariates adjustment. In adjusted models, Black women had higher odds of reporting recent Pap screening (84% vs 77%; OR = 1.7; 95% CI = 1.42-2.03), but reported lower odds of receiving a follow-up recommendation subsequent to abnormal test (78% vs 87%; OR = 0.54; 95% CI = 0.31-0.95). CONCLUSION: Black women reported higher cervical cancer screening adherence but lower rates of being informed of an abnormal Pap test and contacted for follow-up treatment. We recommend a multilevel approach to deliver culturally appropriate education and communication for patients, physicians, clinicians in training, and clinic level ancillary staff.
Authors: Ashley E Stenzel; Gabriela Bustamante; Courtney A Sarkin; Katherine Harripersaud; Patricia Jewett; Deanna Teoh; Rachel I Vogel Journal: Cancer Date: 2022-05-16 Impact factor: 6.921
Authors: Katie E Lichter; Kimberly Levinson; Anne Hammer; Melissa H Lippitt; Anne F Rositch Journal: Gynecol Oncol Date: 2022-02-01 Impact factor: 5.482
Authors: Maria Sansoni; Erin K Tagai; Emmanuel Lapitan; Kuang-Yi Wen; Jenny Xu; Andrew Belfiglio; Shawna V Hudson; Racquel E Kohler; Enrique Hernandez; Suzanne M Miller Journal: Cancer Causes Control Date: 2022-03-25 Impact factor: 2.532
Authors: Teresa K L Boitano; Peter Ketch; Julia G Maier; Christine T Nguyen; Warner K Huh; J Michael Straughn; Isabel C Scarinci Journal: Gynecol Oncol Rep Date: 2022-07-16